Not applicableStudy completedNCT03143764What this trial is testingCardiorespiratory Fitness Using Electrically Assisted BicyclesWho this might be right forDiabetes Mellitus, Type 2 University of Bergen 25
Post-approval studies (Phase 4)Study completedNCT01679899What this trial is testingEffect of Anti-diabetic Drugs on Bone Metabolism and Glycemic VariabilityWho this might be right forType 2 Diabetes MellitusMenopauseOsteoporosis+1 more Centro de Diabetes Curitiba Ltda 56
Testing effectiveness (Phase 2)Study completedNCT02653599What this trial is testingEvaluate Safety and Efficacy of TTP273 for 12 Weeks in Subjects With Type 2 DiabetesWho this might be right forType 2 Diabetes Mellitus vTv Therapeutics 174
Not applicableStudy completedNCT01153516What this trial is testingDiabetes and Gastric By- PassWho this might be right forType 2 Diabetes University of Texas Southwestern Medical Center 22
Not applicableLooking for participantsNCT06745544What this trial is testingImpact of Screening and Multicomponent Exercise on Fall Rates, Fractures, and Cardiovascular Health in DiabetesWho this might be right forType 2 DiabetesOsteoporosisDiabetic Neuropathies+2 more Aalborg University Hospital 490
Large-scale testing (Phase 3)Study completedNCT00099944What this trial is testingEfficacy and Safety of Vildagliptin in Combination With Glimepiride in Patients With Type 2 DiabetesWho this might be right forDiabetes Mellitus, Type 2 Novartis Pharmaceuticals 515
Not applicableStudy completedNCT01793909What this trial is testingType 2 Diabetes and Exercise Function in Single Leg ExercisesWho this might be right forType 2 Diabetes University of Colorado, Denver 55
Post-approval studies (Phase 4)Study completedNCT03089333What this trial is testingEffects of SGLT2 Inhibitor on Hemodynamic Parameters in Resistant Hypertensive SubjectsWho this might be right forHypertensionDiabetes Mellitus, Type 2Blood Pressure+4 more University of Campinas, Brazil 16
Large-scale testing (Phase 3)Study completedNCT01594333What this trial is testingCardiovascular Inflammation Reduction TrialWho this might be right forCardiovascular Disease Brigham and Women's Hospital 4,786
Large-scale testing (Phase 3)Study completedNCT01023581What this trial is testingEfficacy and Safety of Alogliptin Plus Metformin in Patients With Type 2 DiabetesWho this might be right forDiabetes Mellitus, Type 2 Takeda 784
Testing effectiveness (Phase 2)Study completedNCT02205528What this trial is testingOnce-Daily NNC0090-2746 in Participants With Type 2 Diabetes Inadequately Controlled With MetforminWho this might be right forDiabetesDiabetes Mellitus Type 2 Novo Nordisk A/S 108
Large-scale testing (Phase 3)Study completedNCT01755156What this trial is testingEvaluate the Safety, Tolerability, and Efficacy of the Addition of Omarigliptin (MK-3102) to Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Therapy (MK-3102-024)Who this might be right forType 2 Diabetes Mellitus Merck Sharp & Dohme LLC 402
Post-approval studies (Phase 4)Study completedNCT05780151What this trial is testingRemote And Decentralised Innovative Approaches to Clinical Trials (RADIAL)Who this might be right forDiabetes Mellitus, Type 2 Mira Zuidgeest 107
Post-approval studies (Phase 4)Study completedNCT03007329What this trial is testingEffects of Combined Dapagliflozin and Exenatide Versus Dapagliflozin and Placebo on Ectopic Lipids in Patients With Uncontrolled Type 2 Diabetes Mellitus.Who this might be right forSteatosis, LiverType2 Diabetes Medical University of Vienna 34
Not applicableEnded earlyNCT05372445What this trial is testingMicrobiome and Health Indicators in People With Obesity, Prediabetes and Type 2 Diabetes Undergoing a Lifestyle InterventionWho this might be right forDiabetes Mellitus, Type 2ObesityPreDiabetes National Council of Scientific and Technical Research, Argentina 468
Large-scale testing (Phase 3)Study completedNCT01076075What this trial is testingEvaluate the Safety and Efficacy of Sitagliptin 100 mg in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control (MK-0431-229)Who this might be right forType 2 Diabetes Mellitus Merck Sharp & Dohme LLC 427
Early research (Phase 1)Study completedNCT06766500What this trial is testingPharmacokinetics and Bioequivalence Study of Empagliflozin+Metformin Hydrochloride 5 mg/850 mg Film-coated Tablets (Gedeon Richter Plc., Hungary) Versus Synjardy® 5 mg/850 mg Film-coated Tablets (Boehringer Ingelheim International GmbH, Germany)Who this might be right forDiabetes Mellitus Type 2 Gedeon Richter Plc. 64
Not applicableUnknownNCT05847400What this trial is testingPredictors of Chronic Kidney Disease Among Type 2 Diabetic Patients in Assiut University HospitalsWho this might be right forType 2 Diabetes With Renal Manifestations Assiut University 200
Not applicableStudy completedNCT03263351What this trial is testingDepression & Insulin Sensitivity in AdolescentsWho this might be right forType2 DiabetesType 2 Diabetes MellitusInsulin Sensitivity+3 more Colorado State University 147
Post-approval studies (Phase 4)WithdrawnNCT00994253What this trial is testingEvaluating the Effect of Aliskiren Versus HCTZ on Coronary Flow Reserve in Hypertensive Type II DiabeticsWho this might be right forHypertensionDiabetes Type 2 Corewell Health East